1. P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 AND THE EMMY FRENCH COHORT. (23rd June 2022) Authors: Decaux, O.; Hulin, C.; Perrot, A.; Macro, M.; Frenzel, L.; Diels, J.; Perualila, N. J.; Ghilotti, F.; Haefliger, B.; Goldsztajn, E.; Vernet, S.; Thevenon, J.; Willaime, M.; Texier, N.; Schecter, J. M.; Madduri, D.; Jackson, C.; Valluri, S.; Moreau, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL-LIFE EXPERIENCE OF EMMY. (23rd June 2022) Authors: Hulin, C.; Macro, M.; Perrot, A.; Royer, B.; Caillot, D.; Belhadj, K.; Frenzel, L.; Benramdane, R.; Demarquette, H.; Bareau, B.; Darre, S.; Calmettes, C.; Le Calloch, R.; Bouketouche, M.; Laribi, K.; Texier, N.; Willaime, M.; Deal, C.; Moreau, P.; Decaux, O. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P956: EMMY COHORT: MANAGEMENT OF NEWLY DIAGNOSED OR RELAPSED/ REFRACTORY MULTIPLE MYELOMA IN PATIENTS AGED OF 80 YEARS AND OVER. (23rd June 2022) Authors: Macro, M.; Decaux, O.; Perrot, A.; Royer, B.; Chretien, M.; Belhadj, K.; Mohty, M.; Frenzel, L.; Leleu, X.; Dib, M.; Allangba, O.; Zunic, P.; Botoc, I.; Malfuson, J.; Moreau, P.; Garlantazec, R.; Texier, N.; Germain, R.; Deal, C.; Hulin, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗